TITLE
Nathaniel S. Treister: Oral chronic graft-versus-host disease
TALK INFO
In his talk on oral chronic graft-versus-host disease (cGVHD), Nathaniel S. Treister discusses the complexities and challenges of diagnosing and managing this condition. He highlights the impact of cGVHD on oral health, emphasizing symptoms such as mucosal dryness, pain, and difficulty in eating. Treister explores current treatment strategies, including systemic therapies and local interventions, and underscores the importance of multidisciplinary care in improving patient outcomes. He also addresses ongoing research aimed at better understanding the pathophysiology of cGVHD and developing more effective treatments.
THIS EVENT IS ACCREDITED
CLINICAL PATHWAY
Pathology, Medical Assessment and Management
SPEAKER
DATE
19/05/25
LEARNING OBJECTIVES
By the end of this session, participants will be able to:
Describe the pathophysiology and clinical presentation of oral chronic graft-versus-host disease.
Identify key oral manifestations of cGVHD, including mucosal dryness, pain, and functional impairment.
Discuss diagnostic challenges and assessment strategies for oral cGVHD in clinical practice.
Evaluate current management approaches, including systemic therapies and local oral interventions.
Recognize the role of multidisciplinary care in optimizing oral health and overall patient outcomes.
Summarize emerging research directions aimed at improving understanding and treatment of oral cGVHD.
ABOUT THE SPEAKER
Dr. Nathaniel S. Treister DMD, DMSc is Chief of the Division of Oral Medicine and Dentistry at Brigham and Women’s Hospital and Clinical Director of Oral Medicine and Oral Oncology at the Dana-Farber/Brigham and Women's Cancer Center in Boston, Massachusetts. Dr. Treister earned his DMD from the University of Pennsylvania School of Dental Medicine and subsequently completed his Oral Medicine and Oral Biology training at the Harvard School of Dental Medicine, where he is an Associate Professor of Oral Medicine in the Department of Oral Medicine, Infection and Immunity. He is board certified in Oral Medicine and practices at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Boston Children’s Hospital, and Dartmouth-Hitchcock Medical Center, with special interest in oral mucosal diseases, salivary gland diseases, orofacial pain disorders, and oral complications in cancer patients. He has published extensively in the field of oral medicine with an emphasis on oral complications of allogeneic hematopoietic cell transplantation and oral graft-versus-host disease, and is a past president of the American Academy of Oral Medicine. He is co-principal investigator of an NIH R01 grant entitled “Long Term Oral Health Outcomes in the Chronic GVHD Consortium” and serves as site principal investigator for an NIH U01 grant entitled “Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients”.
CE ACCREDITATION
surgeOn is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. surgeOn designates this activity for 1 credit hour of continuing education credits.
This event may also be accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. If you are a learner based in the U.S. or Canada EACCME credits are recognized by the American Medical Association (AMA) and the Royal College of Physicians and Surgeons of Canada.
DECLARATION
In accordance with criterion 13 of document UEMS 2023.07.rev “EACCME® Criteria for the Accreditation of Live Educational Events (LEEs)” and the Standard v. Commercial or Promotional Conflict of Interest, published by the American Dental Association Continuing Education Recognition Program (ADA CERP), all surgeON presenters sign a Conflict of Interest form to document all perceived or actual conflicts of interest for the last 3 years, whether due to a financial or other relationship. This document can be viewed at the beginning of the event or on request by emailing info@surgeon-events.org No fee, honorarium or arrangement for re-imbursement of expenses in relation to the this event has been provided to the speaker.
